Related Experiment Video
Updated: May 9, 2026

10:32
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Assessment of sensorimotor function in mouse models of Parkinson's disease
Sheila M Fleming1, Osunde R Ekhator, Valentins Ghisays
1Department of Psychology, University of Cincinnati, USA.
Journal of Visualized Experiments : Jove
|July 16, 2013
Summary
This study introduces a new battery of sensorimotor tests for mice, crucial for evaluating Parkinson's disease (PD) treatments. These accessible and sensitive tests aid in characterizing PD mouse models and assessing therapeutic efficacy.
Area of Science:
- Neuroscience
- Pharmacology
- Animal Models
Background:
- Sensitive behavioral outcome measures are vital for preclinical therapeutic evaluation in neurodegenerative diseases.
- Sensorimotor tests are fundamental for assessing therapeutic efficacy in Parkinson's disease (PD) preclinical trials.
- Existing rodent sensorimotor tests are often unsuitable for genetic mouse models of PD.
Purpose of the Study:
- To develop and validate a battery of sensorimotor tests for mice.
- To provide sensitive, easy-to-implement, and low-cost measures for PD research.
- To aid in characterizing novel genetic mouse models of PD and evaluating disease-modifying therapies.
Main Methods:
- Adapted established rat sensorimotor tests for mice.
- Developed a novel battery of sensorimotor tests.
- Utilized the test battery across various mouse models of PD.
Main Results:
- The developed test battery demonstrated sensitivity across diverse mouse models of PD.
- The tests are easy to implement and cost-effective.
- The battery proved useful for characterizing PD mouse models and assessing therapeutic interventions.
Conclusions:
- The proposed sensorimotor test battery is a valuable tool for preclinical PD research in mice.
- This approach facilitates the characterization of genetic PD models and the evaluation of novel therapeutics.
- The tests offer a sensitive, accessible, and economical method for advancing PD drug discovery.

